» Articles » PMID: 33935751

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease

Overview
Journal Front Pharmacol
Date 2021 May 3
PMID 33935751
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are two typical neurodegenerative diseases that increased with aging. With the emergence of aging population, the health problem and economic burden caused by the two diseases also increase. Phosphatidylinositol 3-kinases/protein kinase B (PI3K/AKT) signaling pathway regulates signal transduction and biological processes such as cell proliferation, apoptosis and metabolism. According to reports, it regulates neurotoxicity and mediates the survival of neurons through different substrates such as forkhead box protein Os (FoxOs), glycogen synthase kinase-3β (GSK-3β), and caspase-9. Accumulating evidences indicate that some natural products can play a neuroprotective role by activating PI3K/AKT pathway, providing an effective resource for the discovery of potential therapeutic drugs. This article reviews the relationship between AKT signaling pathway and AD and PD, and discusses the potential natural products based on the PI3K/AKT signaling pathway to treat two diseases in recent years, hoping to provide guidance and reference for this field. Further development of Chinese herbal medicine is needed to treat these two diseases.

Citing Articles

Interplay between PI3k/AKT signaling and caspase pathway in Alzheimer disease: mechanism and therapeutic implications.

Bhatia V, Vikram V, Chandel A, Rattan A Inflammopharmacology. 2025; .

PMID: 40088370 DOI: 10.1007/s10787-025-01715-z.


Rotenone Induces Parkinsonism with Constipation Symptoms in Mice by Disrupting the Gut Microecosystem, Inhibiting the PI3K-AKT Signaling Pathway and Gastrointestinal Motility.

Liu L, Zhao Y, Yang W, Fan Y, Han L, Sheng J Int J Mol Sci. 2025; 26(5).

PMID: 40076704 PMC: 11899888. DOI: 10.3390/ijms26052079.


A novel integrative multimodal classifier to enhance the diagnosis of Parkinson's disease.

Zhou X, Parisi L, Huang W, Zhang Y, Huang X, Youseffi M Brief Bioinform. 2025; 26(2).

PMID: 40062615 PMC: 11891661. DOI: 10.1093/bib/bbaf088.


Network pharmacology and metabolomics analysis of Tinospora cordifolia reveals BACE1 and MAOB as potential therapeutic targets for neuroprotection in Alzheimer's disease.

Amrutha S, Abhinand C, Upadhyay S, Parvaje R, Prasad T, Modi P Sci Rep. 2025; 15(1):8103.

PMID: 40057579 PMC: 11890609. DOI: 10.1038/s41598-025-92756-5.


Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer's disease.

Zhao J, Li Z, Zhang R, Yu H, Zhang L BMC Complement Med Ther. 2025; 25(1):94.

PMID: 40055645 PMC: 11889937. DOI: 10.1186/s12906-025-04771-8.


References
1.
Wang X, Pang L, Zhang Y, Xu J, Ding D, Yang T . Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson's Disease. Neurochem Res. 2018; 43(4):938-947. DOI: 10.1007/s11064-018-2499-6. View

2.
Zhang Y, Zhang L, Chen X, Zhang N, Li G . Piceatannol attenuates behavioral disorder and neurological deficits in aging mice via activating the Nrf2 pathway. Food Funct. 2017; 9(1):371-378. DOI: 10.1039/c7fo01511a. View

3.
Parkinson G, Hanley J . Mechanisms of AMPA Receptor Endosomal Sorting. Front Mol Neurosci. 2018; 11:440. PMC: 6289981. DOI: 10.3389/fnmol.2018.00440. View

4.
Zou X, Feng X, Fu Y, Zheng Y, Ma M, Wang C . Icariin Attenuates Amyloid-β (Aβ)-Induced Neuronal Insulin Resistance Through PTEN Downregulation. Front Pharmacol. 2020; 11:880. PMC: 7296100. DOI: 10.3389/fphar.2020.00880. View

5.
Ma B, Meng X, Wang J, Sun J, Ren X, Qin M . Notoginsenoside R1 attenuates amyloid-β-induced damage in neurons by inhibiting reactive oxygen species and modulating MAPK activation. Int Immunopharmacol. 2014; 22(1):151-9. DOI: 10.1016/j.intimp.2014.06.018. View